Risk factors in the prediction of long‐term patency of Resonance metallic ureteric stent in malignant ureteric obstruction

OBJECTIVES: Cancer is the second leading cause of death globally in 2018 with an estimated 9.6 million deaths. The costs of managing malignant ureteric obstruction (MUO) is a significant burden to any healthcare system. However, the management of MUO has long been a challenge for urologists. The sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Brian S. H., Chiu, Peter K. F., Lam, Wayne, Wong, Julius H. F., Wong, Charles K. W., Lai, Terence C. T., Tsang, Chiu‐Fung, Ng, Ada T. L., Chan, Chi‐Kwok, Ma, Wai‐Kit, Ng, Chi‐Fai, Tsu, James H. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988516/
https://www.ncbi.nlm.nih.gov/pubmed/35474710
http://dx.doi.org/10.1002/bco2.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988516/
https://www.ncbi.nlm.nih.gov/pubmed/35474710
http://dx.doi.org/10.1002/bco2.14

Ejemplares similares